MedWatch

Eargo gets second warning from Nasdaq for missing reports

US-based hearing firm Eargo, which has just settled a USD 34.4m case in the US, is now being threatened with delisting on the Nasdaq Stock Market in New York due to three consecutive missing financial reports.

Christian Gormsen, CEO of Eargo | Photo: Eargo / PR

Hearing firm Eargo, which is led by Danish national Christian Gormsen, has run into trouble with the Nasdaq Stock Market in New York – again.

In a press release, the firm reports to have received a letter from Nasdaq New York, in which the financial institution imposes a May 19 deadline on the company, or else be delisted on May 23.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs